Russia Makes It Easier For Regional Generics To Enter Market
This article was originally published in PharmAsia News
Executive Summary
Global drug makers may be facing unusual competition for making it onto Russia's list of drug-buying preferences as the approval of cheaper rivals produced by pharmas in its Eastern Europe region enjoy faster approvals.